Transforming growth factor-beta signaling alters substrate permeability and tight junction protein expression at the blood-brain barrier during inflammatory pain
about
Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in strokeTGFbeta1 stimulates the over-production of white matter astrocytes from precursors of the "brain marrow" in a rodent model of neonatal encephalopathyTransporters at CNS barrier sites: obstacles or opportunities for drug delivery?The central role of hypothalamic inflammation in the acute illness response and cachexiaPeptides at the blood brain barrier: Knowing me knowing youTargeting transporters: promoting blood-brain barrier repair in response to oxidative stress injuryP-glycoprotein modulates morphine uptake into the CNS: a role for the non-steroidal anti-inflammatory drug diclofenacInterleukin-25 expressed by brain capillary endothelial cells maintains blood-brain barrier function in a protein kinase Cepsilon-dependent manner.Stromal regulation of vessel stability by MMP14 and TGFbeta.Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery?CD8 T cell-initiated vascular endothelial growth factor expression promotes central nervous system vascular permeability under neuroinflammatory conditions.Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase).Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differencesClaudins and the modulation of tight junction permeability.Inflammatory pain signals an increase in functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrierTargeting the neurovascular unit for treatment of neurological disorders.TGFβs modulate permeability of the blood-epididymis barrier in an in vitro modelAttenuation of acute stroke injury in rat brain by minocycline promotes blood-brain barrier remodeling and alternative microglia/macrophage activation during recovery.Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.Transforming growth factor-β1 regulates Cdk5 activity in primary sensory neurons.Tempol modulates changes in xenobiotic permeability and occludin oligomeric assemblies at the blood-brain barrier during inflammatory painSinularin from indigenous soft coral attenuates nociceptive responses and spinal neuroinflammation in carrageenan-induced inflammatory rat model.STAT3-mediated astrogliosis protects myelin development in neonatal brain injury.Brain endothelial dysfunction in cerebral adrenoleukodystrophy.Targeted drug delivery to treat pain and cerebral hypoxiaTight junction modulation of the blood brain barrier: CNS delivery of small moleculesNeurovascular unit in chronic pain.Early inhibition of MMP activity in ischemic rat brain promotes expression of tight junction proteins and angiogenesis during recovery.Acetaminophen modulates P-glycoprotein functional expression at the blood-brain barrier by a constitutive androstane receptor-dependent mechanismTGFβ1 exacerbates blood-brain barrier permeability in a mouse model of hepatic encephalopathy via upregulation of MMP9 and downregulation of claudin-5Altered expression of claudin family proteins in Alzheimer's disease and vascular dementia brains.Tight junction proteins expression and modulation in immune cells and multiple sclerosisHeterogeneity of microglial activation in the innate immune response in the brain.Cytokine signaling modulates blood-brain barrier function.Hypoxia/reoxygenation stress signals an increase in organic anion transporting polypeptide 1a4 (Oatp1a4) at the blood-brain barrier: relevance to CNS drug delivery.Transforming growth factor-β in normal nociceptive processing and pathological pain models.Breaking the barrier in stroke: what should we know? A mini-review.Regulation of claudins in blood-tissue barriers under physiological and pathological statesP-glycoprotein trafficking as a therapeutic target to optimize CNS drug delivery.Drug delivery to the ischemic brain.
P2860
Q26864317-B8278942-4716-44E4-A70C-6D38B0A10395Q27333559-924F9257-15D4-4A4F-AB22-45F5495A05EBQ27690256-BCF22925-0057-4F2A-A8D8-2C59D1243E7BQ28080648-F4016C28-C073-4C21-9397-3C98B575A3AAQ28083963-79BDC220-CBDD-43EE-B615-647CA9978FB1Q28088708-E937BDDE-2B78-40D8-835E-28FB9217CB97Q28539683-2A4E0B0B-6047-40CF-8286-90790F5E1F15Q33553749-9E306999-06F2-4DCC-9015-BF483148967AQ33815414-631F0D52-B587-4BA9-948F-72BC98222B4EQ33893813-ED946CD5-A028-447C-81ED-2F379D5619BFQ33957132-34D97A93-EAF6-4999-BA2F-BE2DF40F42A7Q34022792-DA1615A2-7B6D-4B59-8927-C6D72FC56275Q34608061-89D710DC-4DD9-4909-AA67-1D6F88C26152Q34650517-B48FEA60-CC5B-4EEE-80A8-A41654E16163Q34702220-10C87F11-6E1D-4DB7-9939-5B8E07D05CFAQ34974827-162D726E-B790-40D9-989C-2E5DFB0BC7A8Q35043980-F6EFB698-47FA-447E-AED8-5AA8BA942710Q35120831-FF9927E9-F9BF-4145-8865-2F6B93401316Q35855634-0293FE98-023A-4B8A-B636-F158C66723D9Q35956465-419B2204-EF0D-4B0D-BDF5-80FDA69E96F2Q35964989-6AD89319-3300-448A-930C-E75B7381B930Q36329843-113521CF-ACDC-4311-9534-F27E1D233A7AQ36445816-0DE11CCC-464D-4CE9-AFF7-E2D073B579EBQ36515946-19C63932-47CA-4EAF-B680-2BE87F485733Q36591611-2722D4DD-AE4B-4F38-A690-A7FD6AEE4877Q36812411-52259EB6-E602-4101-84AE-1B928C375B08Q36942721-03DDCB95-2192-4D8D-AE91-544A511FEF92Q36994351-1B5E5AE4-F065-44EF-BEB3-D52A57766611Q37252086-1CA0F592-B6AE-4D47-A139-E9D6D2B63F76Q37292152-C161C2B1-485F-4358-9DAB-E0FD2F8709C0Q37294353-65458ED3-D28C-4A4B-8417-23691D66D231Q37294615-D5515BDA-80B8-4EF9-8797-9817508A3054Q37572598-14ACB309-5BE0-4720-9C93-961368A978C7Q37612092-77DD95C2-18EC-4E34-9AC9-DE0C9A7FA3BDQ37695344-7E72A111-89DF-45CB-B0C9-65B7461ADF50Q37962474-7589EFB2-AECF-4173-8BE3-3D3C38DF4AB0Q38009070-A0600898-2CF3-4A20-BB53-58415D746714Q38199105-A8113C60-139E-41A2-A3CF-2423CCAEE308Q38259301-40D500A6-EDFB-43CC-A27E-21DCD5770170Q38259305-F2220446-DDB4-4914-B3A5-E21909C5CD50
P2860
Transforming growth factor-beta signaling alters substrate permeability and tight junction protein expression at the blood-brain barrier during inflammatory pain
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Transforming growth factor-bet ...... rrier during inflammatory pain
@en
Transforming growth factor-bet ...... rier during inflammatory pain.
@nl
type
label
Transforming growth factor-bet ...... rrier during inflammatory pain
@en
Transforming growth factor-bet ...... rier during inflammatory pain.
@nl
prefLabel
Transforming growth factor-bet ...... rrier during inflammatory pain
@en
Transforming growth factor-bet ...... rier during inflammatory pain.
@nl
P2093
P2860
P356
P1476
Transforming growth factor-bet ...... rrier during inflammatory pain
@en
P2093
Christine M Solinsky
Kristin M Demarco
Lucy Sanchez-Covarrubias
Patrick T Ronaldson
Thomas P Davis
P2860
P304
P356
10.1038/JCBFM.2009.32
P577
2009-03-25T00:00:00Z